Your search results are below. For a different search, enter another term below and click on the "Search" button:
-
401. Who leads Exact Sciences? 23 things to know
Exact Sciences is a global cancer diagnostic company that was formed in 1995. Its flagship product, Cologuard, is a noninvasive colorectal cancer screening test that largely brought the company to where ...22 July 2020 -
402. Despite COVID-19, GI is growing & more: 8 GI industry key notes
... with colorectal, pancreatic or gastric cancer could be affected by delayed surgical care. Read more. Catalyst Healthcare Real Estate completed a 50,000-square-foot medical office building for Orlando ...15 July 2020 -
403. How surgical delays affect colorectal, pancreatic & gastric cancer patients: 4 study findings
A study published by researchers at Boston-based Beth Israel Deaconess Medical Center examined how patients with colorectal, pancreatic or gastric cancer could be affected by delayed surgical care. The ...10 July 2020 -
404. Maine hospital expands GI services
... to not delay normal preventive screenings because of the COVID-19 pandemic. "The risk of deferring screenings for colorectal cancer, for example, are far greater than the risk of COVID-19," Dr. Bernadino ...09 July 2020 -
405. Guideline aims to address COVID-19-delayed CRC screening
About 18,800 colorectal cancer diagnoses were missed or delayed from early March and early June because of the COVID-19 pandemic, the National Colorectal Cancer Roundtable claims in a recently published ...08 July 2020 -
406. How PE Practice Solutions is approaching growth going forward & more: 4 GI industry key notes
... stats. The colonoscopy surge is coming, and it may cause clinicians to rethink patient prioritization, strain endoscopy capacity, and lead to more late-stage colorectal cancer diagnosis. Read more. ...01 July 2020 -
407. Undergoing initial CRC screening at 40 cost-effective down the line, study says
Screening patients for colorectal cancer at 40 years old proved to be more cost-effective than starting screening later, according to a study published in Preventive Medicine. The study, reported on ...29 June 2020 -
408. Colonoscopy surge could strain capacity — 4 insights
The colonoscopy surge is coming, and it may cause clinicians to rethink patient prioritization, strain endoscopy capacity, and lead to more late-stage colorectal cancer diagnosis, Medscape reports. What ...26 June 2020 -
409. The best pediatric GI hospitals & more: 6 GI industry key notes
... that the company is advising shareholders against accepting. Fight Colorectal Cancer held a virtual symposium June 11 to discuss the rising incidence rate of early-onset colorectal cancer. The World ...17 June 2020 -
410. Fight CRC hosting symposium on early-onset CRC
Fight Colorectal Cancer is holding a virtual symposium June 11 to discuss the rising incidence rate of early-onset colorectal cancer. Any CRC case in a patient under 50 years old is considered early-onset. ...11 June 2020 -
411. Seattle Cancer Care Alliance opens GI cancer clinic
... rooms that allow patients to receive all their medical oncology care in one room instead of having to move throughout the building. SCCA-affiliated clinicians will treat colorectal, pancreatic, liver ...03 June 2020 -
412. IBD, celiac disease have common connection & more: 5 GI industry key notes
... a common connection. Read more. Modernizing Medicine's integrated payment processing platform, Modmed Pay, is now available to medical practices. Early diagnostic screening for colorectal cancer continues ...27 May 2020 -
413. Long-term CRC risk drops after single negative colonoscopy
A negative screening colonoscopy led to reduced colorectal cancer incidence and mortality rates for up to 17.4 years, according to a study published in the Annals of Internal Medicine and reported on in ...27 May 2020 -
414. Study further validates effectiveness of early CRC screening — 3 insights
Early diagnostic screening for colorectal cancer continues to be essential in reducing CRC-related mortality rate, according to Pharmacy Times. Three things to know: 1. CRC has a 64.4 percent five-year ...20 May 2020 -
415. How to reopen your endoscopy center
... elective cases like screening for colorectal cancer, Barrett's esophagus, gastric intestinal metaplasia, and bariatric procedures when appropriate. Before performing any case, centers should screen patients ...13 May 2020 -
416. How Cologuard compares to FIT & more: 6 GI industry key notes
... patients. Read more. CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity. ...06 May 2020 -
417. Cologuard may be more applicable option for Medicare population than FIT — 4 insight
... the CRC-AIM model to see how a Medicare population would use a triennial multi-target stool DNA test, Cologuard, compared to annual FIT testing. The model uses natural history and colorectal cancer screening ...05 May 2020 -
418. Initial CRC blood test results show promise
CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity. Researchers ...04 May 2020 -
419. Liquid biopsy tests, conventional screening for cancer could present complete picture
... a 99.6 percent specificity rate. The blood test initially detected the following cancers: lymphomas (two), colorectal (two), appendix (one), uterine (two), thyroid (one), kidney (one), lung (nine), ...29 April 2020 -
420. More early-onset CRC cases could be caught by examining family history
Clinicians can help catch early-onset colorectal cancer by consistently screening and recording a patient's family history and proceeding with preventive screening when appropriate, according to a new set ...21 April 2020